Clinical Trials in San Francisco

Showing 7121-7140 of 9,883 trials

High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children

NCT00495521

The purpose of this 4 week study is to determine whether PASER®, an approved delayed-release oral formulation of 4-aminosalicylic acid, in doses of 50 milligrams per kilogram three times daily for 2 weeks followed by 50 milligrams per kilogram twice daily for 2 weeks, will resolve an acute flare of ileocecal Crohn's disease.

Crohn's Disease

Jacobus Pharmaceutical2 participantsStarted Jun 2007

Los Angeles, California, United States • San Francisco, California, United States • Atlanta, Georgia, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease

NCT00620451

This study was conducted to assess the safety and efficacy of larazotide acetate versus placebo in inducing remission in subjects with active celiac disease.

Celiac Disease

9 Meters Biopharma, Inc.105 participantsStarted Feb 2008

Orange, California, United States • San Francisco, California, United States • Torrington, Connecticut, United States +30 more locations

High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children

Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease

Find Trials by Condition in San Francisco

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease

A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

Top-Down Executive Control in Traumatic Brain Injury (TBI), PTSD and Combined

Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.

THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial

Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)

A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation

Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis

A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab

Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis